1[1]Stanley TB, Wu SM, Houben RL, et al. Role of propeptide and gamma-glutamic acid domine of Ⅸ for in vitro carboxylation by the vitamin K-departent carboxylase [J]. Biochemistry, 1998, 37 ( 38 ): 13262 -13268.
2[2]Craciun AM, Groenenvon MM, Vermeer C. Nutrtion vitamin K intake and urinary garnma-carboxyglutamate excretion on the rat[J]. Biochem Biophys Acta, 1997,1334(1) :44 - 50.
3[3]Sato T, Ohtani Y, Yamada Y, et al. Difference in the metabolism of vitamin K between liver and bone in vitamin K-deficient rats[J ]. Br J Nutr, 2002,87 (4): 307-314.
4[4]Itoh S, Onishi S. Developmental changes of vitamin K epoxidase and reductase activities involved in the vitamin K cycle in human liver[J]. Early Hum Dev,2000,57(1): 15 - 23.
5[5]Kohlmeier M, Saupe J, Schaefer K, et al. Bone fractrure history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype[J]. Calcif Tissue Int, 1998,62(3) :278 - 281.
6[6]Hara K, Kobayashi M, Akiyama Y. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats [J]. Bone,2002, 31(5) :575 -581.
7[7]Ozuru R, Sugimoto T, Yamaguchi T, et al. Time-de-pendent effects of vitamin K2 (menatetrenone) on bone metabolism in postmenopausal women [ J ]. Endocr J,2002,49(3): 363 - 370.
8[8]Cracium AM, Who J, Knapen MH, et al. Improved bone metubolism in female elite athletes after vitamin K supplementation[ J ]. Int J sports Med (Germany),1998,56(1 ) :479 - 484.
9[9]Sato Y, Honoda Y, Kunoh H, et al. Long -term oral ahticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillition[J]. Stroke, 1997,28(2) :2390 - 2394.
10[10]Kanai T, Takagi T, Masuhiro K, et al. Serum Vitamin K level and bone mineral density in post-menopausal women[J]. Int J Gynecol Obstet, 1997,56(1) :25 - 30.
